NCT06197438 2024-01-09
Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
Fujian Cancer Hospital
Henan Cancer Hospital
Henan Cancer Hospital
Velindre NHS Trust
Taipei Veterans General Hospital, Taiwan
National Cancer Center, Korea
National Cancer Center, Korea
National Cancer Center, Korea
National Cancer Center, Korea